Clinical Trial Update: Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of ultra-rush sublingual immunotherapy in children with asthma allergic to grass pollen; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Grass pollen extract sublingual immunotherapy (grass pollen extract for sublingual immunotherapy)

Snippet

Sponsor: Medical University of Lodz | Conditions: Asthma | Phase 4 | Status: COMPLETED